Breaking News Instant updates and real-time market news.

AVAV

AeroVironment

$47.37

-0.72 (-1.50%)

, AMBA

Ambarella

$53.97

1.11 (2.10%)

16:51
03/20/18
03/20
16:51
03/20/18
16:51

Trump looks to sell more lethal drones to allies, Reuters says

President Donald Trump is on the verge of making it "easier to export some types of lethal U.S.-made drones to potentially dozens more allies and partners," said Reuters, citing people familiar with the plan. Companies in the space include AeroVironment (AVAV), Ambarella (AMBA),Boeing (BA) and Kratos Defense (KTOS). Reference Link

AVAV

AeroVironment

$47.37

-0.72 (-1.50%)

AMBA

Ambarella

$53.97

1.11 (2.10%)

BA

Boeing

$337.63

5.87 (1.77%)

KTOS

Kratos Defense

$9.71

0.395 (4.24%)

  • 20

    Mar

  • 30

    May

AVAV AeroVironment
$47.37

-0.72 (-1.50%)

08/30/17
BARD
08/30/17
NO CHANGE
Target $35
BARD
Neutral
AeroVironment results better than feared, says Baird
Baird analyst Peter Arment noted AeroVironment reported better than expected Q1 results and reaffirmed its 2018 guidance, which reflects a relatively flat earnings profile tied to lower-margin mix and higher taxes. Arment maintained his Neutral rating and $35 price target on AeroVironment shares.
10/04/17
ADAM
10/04/17
NO CHANGE
Target $48
ADAM
Hold
AeroVironment price target raised to $48 from $40 at Canaccord
Canaccord analyst Ken Herbert raised his price target on AeroVironment to $48 from $40 as the stock has been substantially outperforming its peers recently. Herbert said he remains skeptical about the potential upside for the Quanix drone system, but he does not believe investors are focused on that market. The commercial drone market is expected to be one of the fastest growing over the next several years. Herbert maintained his Hold rating on AeroVironment shares.
03/07/18
PIPR
03/07/18
NO CHANGE
Target $48
PIPR
Neutral
AeroVironment target raised to $48 on 'solid' Q3 at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for AeroVironment to $48 from $42 saying the company last night reported "solid" Q3 results. Earnings would have beat expectations if not for a deferred tax impact of 13c, Jensen tells investors in a research note. He continues to believe AeroVironment's largest growth opportunity is from sales to international governments. He remains bullish on the company's long-term opportunities but reiterates a Neutral rating on the name.
03/07/18
STFL
03/07/18
NO CHANGE
Target $45
STFL
Hold
Stifel says 'too soon' to upgrade AeroVironment
After AeroVironment reported Q3 revenue that was slightly above consensus and "well ahead" of Stifel analyst Joseph DeNardi's $54M estimate, he said he was surprised to see the stock down about 10% in after-hours trading. However, he attributed that post-report reaction to what was perceived as a weak backlog figure for Q3. That view, though, misses the $45M Puma order announced in conjunction with the report and a "very strong" pipeline of opportunities, said DeNardi, who thinks it is too soon to upgrade the stock but came away from the company's earnings call "more bullish than bearish." He maintains a Hold rating and $45 price target on AeroVironment shares.
AMBA Ambarella
$53.97

1.11 (2.10%)

12/01/17
MSCO
12/01/17
NO CHANGE
Target $60
MSCO
Overweight
Ambarella commentary on computer vision 'notably stronger,' says Morgan Stanley
Morgan Stanley analyst Joseph Moore said Ambarella's commentary on its computer vision chip was notably stronger and he expects to get much more detail in the coming months, pointing to January's Consumer Electronics Show as an important upcoming catalyst. Ambarella management said they had sampled the first version of the CV chip to automotive and surveillance customers and there is a possibility they could announce auto development relationships for CV in 2018, maybe even the first half of the year, noted Moore, who maintains an Overweight rating and $60 price target on Ambarella shares.
01/03/18
OPCO
01/03/18
UPGRADE
OPCO
Outperform
Ambarella upgraded to Outperform from Perform at Oppenheimer
01/03/18
01/03/18
UPGRADE
Target $70

Outperform
Ambarella upgraded to Outperform at Oppenheimer
As previously reported, Oppenheimer analyst Andrew Uerkwitz upgraded Ambarella to Outperform from Perform, with a $70 price target, saying downward revisions are over and core business is sustainable. The analyst expects the conversation to shift toward a computer vision-based thesis, centered on the market potential of CV and the company's position within it.
01/29/18
MSCO
01/29/18
NO CHANGE
Target $65
MSCO
Overweight
Ambarella loss of DJI drone socket a setback, says Morgan Stanley
Morgan Stanley analyst Joseph Moore said DJI's latest drone, the Mavic Air, is not believed to use an Ambarella chip and his best guess is that it uses a custom silicon design. He thinks to some degree this was understood and contemplated by management and perhaps was an element of Ambarella's guidance, but he still views it as a setback and sees some risk to near-term numbers. However, computer vision will protect Ambarella's legacy markets, said Moore, who cut his 2018 estimates but leaves his 2019 numbers unchanged. The analyst keeps his Overweight rating and $65 price target on Ambarella shares.
BA Boeing
$337.63

5.87 (1.77%)

02/13/18
EDJN
02/13/18
UPGRADE
EDJN
Buy
Boeing upgraded to Buy from Hold at Edward Jones
02/13/18
02/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. JPMorgan (JPM) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying he views the recent pullback in the shares as a buying opportunity. 2. Total (TOT) upgraded to Overweight from Equal Weight at Morgan Stanley and to Strong Buy from Outperform at Raymond James. 3. Celgene (CELG) upgraded to Overweight from Equal Weight at Barclays with analyst Geoff Meacham saying the current valuation largely reflects the risk. 4. Quest Diagnostics (DGX) upgraded to Outperform from Neutral at Credit Suisse with analyst A.J. Rice saying he believes the company has "substantial runway on several fronts," including its Optum partnership related to revenue cycle management, which he believes could reduce bad debts and claims denials. 5. Boeing (BA) upgraded to Buy from Hold at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/13/18
JEFF
03/13/18
NO CHANGE
Target $400
JEFF
Buy
Boeing booked 21 widebody orders in February, says Jefferies
Jefferies analyst Sheila Kahyaoglu says the most incremental item in Boeing's February orders report was the booking of 21 widebody orders, including three legacy 777s. The company is adding to its widebody backlog, Kahyaoglu tells investors in a research note. She notes that at current production rates, on average Boeing has more than seven years of production in backlog. The analyst sees support for upcoming rate increases and keeps a Buy rating on Boeing shares with a $400 price target.
03/14/18
JPMS
03/14/18
NO CHANGE
JPMS
Spirit AeroSystems, Boeing weakness appears overdone, says JPMorgan
JPMorgan analyst Seth Seifman said he is not surprised that Spirit AeroSystems (SPR) would underperform after the company made comments at the firm's Aviation, Transportation and Industrials Conference about 737 cost pressure in Q1. He also believes the decline in the stock, as well as in shares of Boeing (BA), appears overdone. He thinks Spirit is "taking a hit" now so that it can meet its commitments to Boeing, noting that the company has maintained its earnings outlook for the year and has a history of conservatism. Seifman added that he does not think this morning's 737 MAX news is the only factor weighing on Boeing and Spirit, however, as reports that President Trump is considering $60B of tariffs on Chinese goods are "likely not helping," but he still thinks a rupture in Boeing's relationship with China is unlikely.
KTOS Kratos Defense
$9.71

0.395 (4.24%)

01/03/18
ADAM
01/03/18
NO CHANGE
Target $15
ADAM
Buy
Kratos Defense backlog provides confidence for 2018, says Canaccord
Canaccord analyst Ken Herbert said Kratos Defense ended 2017 with a healthy backlog and was awarded a year-end U.S. Army contract for aerial drones that provides top-line confidence heading into 2018. He lauded management for delivering on all it said it would in 2017. The analyst said as visibility improves on free cash flow and profit expansion, the stock will continue to grow its multiple. Herbert reiterated his Buy rating and $15 price target on Kratos Defense shares.
02/26/18
ADAM
02/26/18
NO CHANGE
Target $15
ADAM
Buy
Kratos Defense outlook and contract activity are positives, says Canaccord
Canaccord analyst Ken Herbert previewed Kratos Defense's Q4 results, which are expected this week, and said its recent contract activity and updated 2018 guidance will be positives on its conference call. He sees near-term risk to the EBITDA ramp as investments to support growth continue, but he sees the recent contract announcements providing greater confidence in 2018 upside. Herbert reiterated his Buy rating and $15 price target on Kratos Defense shares.
03/02/18
ADAM
03/02/18
NO CHANGE
Target $15
ADAM
Buy
Kratos Defense top-line outlook provides optimism, says Canaccord
Canaccord analyst Ken Herbert noted Kratos Defense reported better than expected revenues and adjusted EBITDA for Q4. He said he was encouraged by management's attention to increasing its focus on working capital, which is reflected in the expected strong free cash flow improvement in 2018. Herbert reiterated his Buy rating and $15 price target on Kratos Defense shares.
03/19/18
ADAM
03/19/18
NO CHANGE
Target $15
ADAM
Buy
Kratos selloff on short report a buying opportunity, says Canaccord
Canaccord Genuity analyst Ken Herbert believes the 11% selloff Friday in shares of Kratos Defense & Security Solutions following Spruce Point Capital Management's short report presents a buying opportunity. Much of Spruce Point's criticism focuses on "older data points with little incremental information," Herbert tells investors in a research note. The analyst believes Kratos will benefit "substantially" from the increased Department of Defense investments in unmanned technology. He thinks the lack of discussion around the defense budget is one of the primary shortcomings of Spruce's short report. Herbert keeps a Buy rating on Kratos Defense with a $15 price target.

TODAY'S FREE FLY STORIES

BCS

Barclays

$8.60

0.11 (1.30%)

14:20
10/23/18
10/23
14:20
10/23/18
14:20
Options
8-strike put buyers in Barclays Bank ahead of earnings »

8-strike put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SELB

Selecta Biosciences

$8.93

-4.44 (-33.21%)

14:19
10/23/18
10/23
14:19
10/23/18
14:19
Recommendations
Selecta Biosciences analyst commentary  »

Selecta Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SLG

SL Green Realty

$92.15

0.36 (0.39%)

14:18
10/23/18
10/23
14:18
10/23/18
14:18
Downgrade
SL Green Realty rating change  »

SL Green Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/23/18
10/23
14:17
10/23/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$133.39

-7.945 (-5.62%)

14:16
10/23/18
10/23
14:16
10/23/18
14:16
Recommendations
Centene analyst commentary  »

Centene should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 14

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/23/18
10/23
14:16
10/23/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$22.65

-1.255 (-5.25%)

14:15
10/23/18
10/23
14:15
10/23/18
14:15
Options
KKR put volume heavy and directionally bearish »

Bearish flow noted in KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

SBH

Sally Beauty

$17.78

0.28 (1.60%)

14:09
10/23/18
10/23
14:09
10/23/18
14:09
Hot Stocks
Sally Beauty unveils Sally Beauty Rewards »

"Sally Beauty …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAD

iCAD

$3.10

-0.02 (-0.64%)

14:06
10/23/18
10/23
14:06
10/23/18
14:06
Hot Stocks
iCAD announces new clinical data on the Xoft Electronic Brachytherapy System »

iCAD announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

AMD

AMD

$24.73

-0.31 (-1.24%)

14:05
10/23/18
10/23
14:05
10/23/18
14:05
Hot Stocks
AMD, Oracle collaborate on EPYC processor-based offering »

At Oracle's (ORCL)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Dec

UNH

UnitedHealth

$261.89

-0.26 (-0.10%)

14:05
10/23/18
10/23
14:05
10/23/18
14:05
Options
UnitedHealth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$152.62

-2.19 (-1.41%)

14:03
10/23/18
10/23
14:03
10/23/18
14:03
Hot Stocks
Facebook introduces Messenger 4 »

In a blog posting,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

14:00
10/23/18
10/23
14:00
10/23/18
14:00
General news
Breaking General news story  »

Dallas Federal Reserve…

KR

Kroger

$28.16

0.17 (0.61%)

13:58
10/23/18
10/23
13:58
10/23/18
13:58
Hot Stocks
Kroger hiring 10,000 associates for holiday season »

The Kroger Co. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

EXAS

Exact Sciences

$63.00

0.68 (1.09%)

13:55
10/23/18
10/23
13:55
10/23/18
13:55
Periodicals
Exact Sciences named a core healthcare short at Hedgeye »

Hedgeye named Exact…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

EOG

EOG Resources

$110.23

-6.03 (-5.19%)

13:55
10/23/18
10/23
13:55
10/23/18
13:55
Options
EOG Resources put volume heavy and directionally bearish »

Bearish flow noted in EOG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

SELB

Selecta Biosciences

$9.06

-4.31 (-32.24%)

, HZNP

Horizon Pharma

$18.52

-0.735 (-3.82%)

13:53
10/23/18
10/23
13:53
10/23/18
13:53
Hot Stocks
Street Fight: Analysts diverge on Selecta Bio's gout drug data read-through »

Shares of Selecta…

SELB

Selecta Biosciences

$9.06

-4.31 (-32.24%)

HZNP

Horizon Pharma

$18.52

-0.735 (-3.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

13:50
10/23/18
10/23
13:50
10/23/18
13:50
General news
Fed's Bostic continues to tout a gradual path of tightening »

Fed's Bostic…

UNP

Union Pacific

$143.76

-3.04 (-2.07%)

13:47
10/23/18
10/23
13:47
10/23/18
13:47
Periodicals
Union Pacific eliminating 475 positions by year end, World-Herald says »

Union Pacific said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

LNG

Cheniere Energy

$61.13

-2.36 (-3.72%)

13:45
10/23/18
10/23
13:45
10/23/18
13:45
Options
Cheniere Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

GOOG

Alphabet

$1,095.61

-4.91 (-0.45%)

, GOOGL

Alphabet Class A

$1,104.31

-6.89 (-0.62%)

13:44
10/23/18
10/23
13:44
10/23/18
13:44
Periodicals
Google will fix Pixel photo saving issue with software update, Verge says »

Google will fix a trouble…

GOOG

Alphabet

$1,095.61

-4.91 (-0.45%)

GOOGL

Alphabet Class A

$1,104.31

-6.89 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

RFP

Resolute Forest

$11.70

-0.12 (-1.02%)

13:41
10/23/18
10/23
13:41
10/23/18
13:41
Conference/Events
Resolute Forest to hold a press conference »

Management announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

AEP

American Electric

$73.15

0.01 (0.01%)

13:40
10/23/18
10/23
13:40
10/23/18
13:40
Hot Stocks
American Electric increases quarterly dividend 8.1% to 67c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 11

    Nov

YEXT

Yext

$18.57

0.18 (0.98%)

, SNAP

Snap

$6.83

-0.01 (-0.15%)

13:39
10/23/18
10/23
13:39
10/23/18
13:39
Hot Stocks
Snapchat joins the Yext knowledge network »

Yext (YEXT) announced a…

YEXT

Yext

$18.57

0.18 (0.98%)

SNAP

Snap

$6.83

-0.01 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 07

    Nov

  • 13

    Nov

YEXT

Yext

$18.57

0.18 (0.98%)

13:35
10/23/18
10/23
13:35
10/23/18
13:35
Hot Stocks
Yext announces next generation of DKM, Yext Brain »

Yext announced the next…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.